1AI — Algorae Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- AU$18.55m
- AU$14.93m
- AU$0.04m
Annual cashflow statement for Algorae Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.098 | 0.117 | 0.023 | 0.002 | 0.033 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.99 | -3.11 | -1.46 | -2.04 | -1.99 |
| Capital Expenditures | -0.01 | 0 | — | -0.004 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.043 | 1.24 | 0.106 | 0.043 | 0 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -0.053 | 1.24 | 0.106 | 0.04 | 0 |
| Financing Cash Flow Items | 0 | — | — | 1.83 | -0.299 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | -0.05 | -0.045 | 4.69 | 1.85 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.95 | -1.94 | -1.4 | 2.67 | -0.128 |